Published in J Med Chem on October 07, 1999
Inhibition of pancreatic cholesterol esterase reduces cholesterol absorption in the hamster. BMC Pharmacol (2004) 0.92
Isocoumarin-based inhibitors of pancreatic cholesterol esterase. Bioorg Med Chem (2008) 0.83
Unnatural polyketide analogues selectively target the HER signaling pathway in human breast cancer cells. Chembiochem (2010) 0.77
Probing stereoselective inhibition of the acyl binding site of cholesterol esterase with four diastereomers of 2'-N-alpha-methylbenzylcarbamyl-1, 1'-bi-2-naphthol. BMC Biochem (2005) 0.75
Purification of glutathione S-transferases from human liver by glutathione-affinity chromatography. Anal Biochem (1977) 2.79
Isolation and characterization of the multiple glutathione S-transferases from human liver. Evidence for unique heme-binding sites. J Biol Chem (1985) 1.96
Purification of glutathione S-transferases by glutathione-affinity chromatography. Methods Enzymol (1981) 1.48
Reduction of trioses by NADPH-dependent aldo-keto reductases. Aldose reductase, methylglyoxal, and diabetic complications. J Biol Chem (1992) 1.45
Nutritional status in a healthy elderly population: vitamin D. Am J Clin Nutr (1982) 1.35
Selective active site inhibitors of human lactate dehydrogenases A4, B4, and C4. Biochem Pharmacol (2001) 1.30
Selective inhibitors of human lactate dehydrogenases and lactate dehydrogenase from the malarial parasite Plasmodium falciparum. J Med Chem (1998) 1.26
Characterization of a hemoglobin-degrading, low molecular weight protease from Plasmodium falciparum. Mol Biochem Parasitol (1986) 1.22
D-lactate production in erythrocytes infected with Plasmodium falciparum. Mol Biochem Parasitol (1991) 1.15
Substrate specificity of human aldose reductase: identification of 4-hydroxynonenal as an endogenous substrate. Biochim Biophys Acta (1995) 1.11
Substrate and cofactor specificity and selective inhibition of lactate dehydrogenase from the malarial parasite P. falciparum. Mol Biochem Parasitol (1997) 1.08
Synthesis and anti-HIV activity of 1,1'-dideoxygossypol and related compounds. J Med Chem (1995) 1.06
Localization and characterization of hemoglobin-degrading aspartic proteinases from the malarial parasite Plasmodium falciparum. Biochim Biophys Acta (1992) 1.03
Antiviral activities of gossypol and its derivatives against herpes simplex virus type II. Pharmacol Res Commun (1986) 1.02
Aldose reductase from human skeletal and heart muscle. Interconvertible forms related by thiol-disulfide exchange. J Biol Chem (1990) 1.01
Kinetic evaluation of substrate specificity in the glyoxalase-I-catalyzed disproportionation of -ketoaldehydes. Biochemistry (1972) 1.00
Deuterium isotope effects and chemically modified coenzymes as mechanism probes of yeast glyoxalase-I. Biochemistry (1973) 0.99
Oxidative stress indices in IDDM subjects with and without long-term diabetic complications. Clin Biochem (2001) 0.99
Inactivation of glutathione reductase by 4-hydroxynonenal and other endogenous aldehydes. Biochem Pharmacol (1997) 0.97
Regulation of the glutathione S-transferase activity of bilirubin transport protein (ligandin) from human liver. Enzymic memory involving protein-protein interactions. J Biol Chem (1983) 0.96
Marker enzymes of Plasmodium falciparum and human erythrocytes as indicators of parasite purity. J Parasitol (1982) 0.94
Purification and characterization of an aminopeptidase from Plasmodium falciparum. Mol Biochem Parasitol (1984) 0.94
Biologically active derivatives of gossypol: synthesis and antimalarial activities of peri-acylated gossylic nitriles. J Med Chem (1986) 0.93
Water and urea transport in human erythrocytes infected with the malaria parasite Plasmodium falciparum. Mol Biochem Parasitol (1990) 0.91
Metabolism of the 2-oxoaldehyde methylglyoxal by aldose reductase and by glyoxalase-I: roles for glutathione in both enzymes and implications for diabetic complications. Chem Biol Interact (2001) 0.91
The kinetic properties and sensitivities to inhibitors of lactate dehydrogenases (LDH1 and LDH2) from Toxoplasma gondii: comparisons with pLDH from Plasmodium falciparum. Mol Biochem Parasitol (2001) 0.90
2-Propylthiouracil does not replace glutathione for the glutathione transferases. J Biol Chem (1984) 0.88
Increased levels of methylglyoxal-metabolizing enzymes in mononuclear and polymorphonuclear cells from insulin-dependent diabetic patients with diabetic complications: aldose reductase, glyoxalase I, and glyoxalase II--a clinical research center study. J Clin Endocrinol Metab (1996) 0.88
Z-2 microsatellite allele is linked to increased expression of the aldose reductase gene in diabetic nephropathy. J Clin Endocrinol Metab (1998) 0.88
Gossypol and derivatives: a new class of aldose reductase inhibitors. J Med Chem (1991) 0.87
Aldehyde and aldose reductases from human placenta. Heterogeneous expression of multiple enzyme forms. J Biol Chem (1990) 0.87
Gossypol binds to a high-affinity binding site on human serum albumin. FEBS Lett (1983) 0.86
Isolation of intracellular parasites (Plasmodium falciparum) from culture using free-flow electrophoresis: separation of the free parasites according to stages. J Parasitol (1982) 0.86
Purification and kinetic study of glyoxalase-I from rat liver, erythrocytes, brain and kidney. Biochim Biophys Acta (1976) 0.86
Characterization of adenine phosphoribosyltransferase from the human malaria parasite, Plasmodium falciparum. Biochim Biophys Acta (1989) 0.84
Aldose and aldehyde reductases from human kidney cortex and medulla. Biochim Biophys Acta (1993) 0.84
Effects of pH and thiols on the kinetics of yeast glyoxalase I. An evaluation of the random pathway mechanism. Biochemistry (1975) 0.84
Aldose reductase-catalyzed reduction of acrolein: implications in cyclophosphamide toxicity. Mol Pharmacol (1994) 0.83
Comparison of proteases from chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum. Biochem Pharmacol (1987) 0.83
Purification and bilirubin binding properties of glutathione S-transferase from human placenta. FEBS Lett (1981) 0.82
S-2-hydroxyacylglutathione hydrolase (glyoxalase II): active-site mapping of a nonserine thiolesterase. Biochemistry (1981) 0.82
Comparison of the antiviral activities of 3'-azido-3'-deoxythymidine (AZT) and gossylic iminolactone (GIL) against clinical isolates of HIV-1. Pharmacol Res (1995) 0.81
Diffusion-dependent rates for the hydrolysis reaction catalyzed by glyoxalase II from rat erythrocytes. Biochemistry (1988) 0.81
NADPH production by the malarial parasite Plasmodium falciparum. Blood (1989) 0.80
Comparative kinetics of Mg2+-, Mn2+-, Co2+-, and Ni2+-activated glyoxalase I. Evaluation of the role of the metal ion. Biochemistry (1977) 0.80
Reactivity-selectivity properties of reactions of carcinogenic electrophiles and nucleosides: influence of pH on site selectivity. Chem Biol Interact (1980) 0.80
Parasite proteases and antimalarial activities of protease inhibitors. Prog Clin Biol Res (1989) 0.80
In vitro regulation of kidney 25-hydroxyvitamin D3-hydroxylase enzyme activities by vitamin D3 metabolites. Molecular specificity and mechanism of action. J Biol Chem (1980) 0.79
Partial purification and characterization of lactate dehydrogenase from Plasmodium falciparum. Mol Biochem Parasitol (1981) 0.79
Physiological substrates of human aldose and aldehyde reductases. Adv Exp Med Biol (1997) 0.78
Influence of curing on the adhesive and thermomechanical properties of an applied acrylic polymer. Pharm Dev Technol (2001) 0.78
Inhibition of human immunodeficiency virus type I replication by derivatives of gossypol. Pharmacol Res (1991) 0.78
Small molecule probes of glyoxalase I and glyoxalase II. Biochim Biophys Acta (1994) 0.78
Glucose inhibition of human fibroblast proliferation and response to growth factors is prevented by inhibitors of aldose reductase. Mech Ageing Dev (1989) 0.77
Binding of gossypol derivatives to human serum albumin. J Pharm Sci (1988) 0.77
Purification of S-2-hydroxyacylglutathione hydrolase (glyoxalase II) from rat erythrocytes. Anal Biochem (1979) 0.77
Relationship of oxidative stress indices to decreased LDL-cholesterol after acute myocardial infarction. Clin Biochem (2000) 0.77
Inhibition of human aldose and aldehyde reductases by non-steroidal anti-inflammatory drugs. Adv Exp Med Biol (1999) 0.76
Growth inhibitory properties of aromatic alpha-ketoaldehydes toward bacteria and yeast. Comparison of inhibition and glyoxalase I activity. J Med Chem (1975) 0.76
Substrate specificity of reduced and oxidized forms of human aldose reductase. Adv Exp Med Biol (1993) 0.76
Isolation and kinetic analysis of the multiple forms of glyoxalase-I from human erythrocytes. Arch Biochem Biophys (1979) 0.75
Purification of aldose reductase from human placenta and stabilization of the inhibitor binding site. Biochem Pharmacol (1988) 0.75
Immunochemical comparisons of proteins that bind heme and bilirubin: human serum albumin, alpha-fetoprotein and glutathione S-transferases from liver, placenta and erythrocyte. Comp Biochem Physiol B (1987) 0.75
In vitro testing of a glyoxalase I inhibitor. Biochem Soc Trans (1993) 0.75
Calorimetric determination of the micro ionization constants of glutathione. Arch Biochem Biophys (1972) 0.75
Direct modulation of 25-hydroxyvitamin D3 hydroxylation in kidney tubules by 1,25-dihydroxy-vitamin D3. Biochem Biophys Res Commun (1978) 0.75
11- and 12-chloromethylbenzo[a]pyrene are potent direct-acting mutagens in the Ames assay. Mutat Res (1985) 0.75
Purification and characterization of 2-oxoaldehyde dehydrogenase from rat liver. Biochim Biophys Acta (1977) 0.75
Inhibition of aldose reductase by gossypol and gossypol-related compounds. Adv Exp Med Biol (1999) 0.75
2-Ketoaldehyde dehydrogenase from rat liver. Methods Enzymol (1982) 0.75
Chemical reactivities and mutagenicities of a series of chloromethylbenzo[a]pyrenes. Chem Biol Interact (1985) 0.75
Polyol and water accumulation in muscle of galactose-fed rats. Biochem Pharmacol (1994) 0.75